Type I and Type II Interferons: Differential Antiviral Actions in Transformed Cells

References

1. Aitenburg B. C., Via D. P., Steiner S. H. 1976; Modification of the phenotype of murine sarcoma virus transformed cells by sodium butyrate. Experimental Cell Research 102:223–231
   [Google Scholar]
2. Baron S., Dianzani F. (Editors) 1977 In The Interferon System: a Current Review to 1978. Texas Reports on Biology and Medicine 35 Galveston: University of Texas Medical Branch;
   [Google Scholar]
3. Bourgeade M. F. 1978; Effet du butyrate de sodium sur la sensibility h l’interf6ron de cellules normales et transformees par le virus du sarcome murin. Comptes Rendus hebdomadaires des Seances de VAcademie des Sciences serie D 287:391–394
   [Google Scholar]
4. Bourgeade M. F., Chany C. 1976; Inhibition of interferon action by cytochalasin B, colchicine, and vinblastine. Proceedings of the Society for Experimental Biology and Medicine 153:501–504
   [Google Scholar]
5. Brailovsky C., Berman L. D., Chany C. 1969; Decreased interferon sensitivity and production in cells transformed by SV 40 and other oncogenic agents. International Journal of Cancer 4:194–203
   [Google Scholar]
6. Brinkley B. R., Fuller G. M., Highfield D. P. 1975; Cytoplasmic microtubules in normal and transformed cells in culture: analysis by tubulin antibody immunofluorescence. Proceedings of the National Academy of Sciences of the United States of America 72:4981–4985
   [Google Scholar]
7. Chany C., Vignal M. 1970; Effect of prolonged interferon treatment on mouse embryonic fibroblasts transformed by murine sarcoma virus. Journal of General Virology 7:203–210
   [Google Scholar]
8. Dianzani F., Slater L., Fleischmann W. R. Jun, Zucca M. 1978; Immune interferon activates cells more slowly than does virus-induced interferon. Proceedings of the Society for Experimental Biology and Medicine 159:94–97
   [Google Scholar]
9. Epstein L. B., Epstein D. J. 1976; Localization of the gene AVG for the antiviral expression of immune and classical interferon to the distal portion of the long arm of chromosome 21. Journal of Infectious Diseases 133:A56–A62
   [Google Scholar]
10. Pollack R., Osborn M., Weber K. 1975; Pattern organization of actin and myosin in normal and transformed cultured cells. Proceedings of the National Academy of Sciences of the United States of America 72:994–998
    [Google Scholar]
11. Salvin S. B., Youngner J. S., Nishio J., Heta R. 1975; Tumor suppression by a lymphokine released into the circulation of mice with delayed hypersensitivity. Journal of the National Cancer Institute 55:1233–1238
    [Google Scholar]
12. Sonnenfeld G., Mandel A. D., Merigan T. C. 1978; Immunoenhancement by murine type II interferon preparation. Cellular Immunology 40:285–293
    [Google Scholar]
13. Sonnenfeld G., Meruelo D., Mcdevitt H. O., Merigan T. C. 1979; Effect of interferon on murine lymphocyte surface antigen expression. I. Studies with type II interferon. Submitted for publication
    [Google Scholar]
14. Wietzerbin J., Stephanos S., Falcoff R., Falcoff E. 1977; Some properties of interferon induced by stimulants of T and B lymphocytes. In The Interferon System: a Current Review to 1978, Texas Reports on Biology and Medicine 35205–211 Edited by Baron S., Dianzani F. Galveston: University of Texas Medical Branch;
    [Google Scholar]
15. Youngner J. S., Salvin S. B. 1973; Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Journal of Immunology 111:1914–1922
    [Google Scholar]